By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





Company News
Soligenix (SNGX) Announces $1.5 Million NCI SBIR Grant Award Supporting The Pivotal Phase III Clinical Trial Of SGX301 For The Treatment Of Cutaneous T-Cell Lymphoma 9/18/2017 6:30:44 AM
Aethlon Medical (AEMD) Receives NCI Contract Award 9/14/2017 11:03:09 AM
BioMarker Strategies Announces Phase II NCI Grant To Continue Development Of Companion Diagnostic Test To Help Select Optimal Therapy For Patients With Non-Small Cell Lung Cancer 9/11/2017 8:16:04 AM
Kite Pharma (KITE) Highlights Publication From The NCI Demonstrating Responses In Patients With Metastatic Solid Tumors Treated With T Cell Receptor (TCR) Therapy Targeting MAGE A3 8/17/2017 7:26:00 AM
SillaJen Announces Collaboration With The NCI For Development Of Combination Therapy With SillaJen's Pexastimogene Devacirepvec (Pexa-Vec) Oncolytic Immunotherapy 8/17/2017 6:18:23 AM
TRACON Pharma (TCON) Announces Positive Results From NCI Phase I/II Trial Of TRC105 And Nexavar In Hepatocellular Cancer Published In Clinical Cancer Research 8/16/2017 7:06:11 AM
SignalRX Pharmaceuticals Awarded $2M Phase II STTR Grant From NCI For The Development Of Epigenetic-Kinase Inhibitors As Anticancer Agents 8/8/2017 9:30:17 AM
Edico Genome Signs Contracts With National Human Genome Research Institute And NCI For Use Of DRAGEN For Cancer Research 8/2/2017 8:42:45 AM
Adaptive Biotech Announces Translational Collaboration With NCI 7/26/2017 8:14:41 AM
VolitionRX To Host A Conference Call Regarding A 13,500 Subject Colorectal Cancer Screening Trial With The Early Detection Research Network Of The U.S. NCI 7/20/2017 6:56:38 AM
12345678910...
//-->